http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012156537-A9

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e459b6d9cc66efbd6417c94813588e27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70996dddc206914ec923aa501a8d4466
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14a92f51d3fd7fc50a764ec419f11f6f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 2012-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c8256231a483e2ca26b249af9abc593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccba7e5e95f13bf65bac35077d94506d
publicationDate 2013-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012156537-A9
titleOfInvention Lysine demethylase inhibitors such as cyclylcylopropamine derivatives for use in the treatment of thrombosis and cardiovascular diseases
abstract The invention relates to methods and compositions for the treatment or prevention of thrombosis, thrombus formation, a thrombotic event or complication, or a cardiovascular disease or event. In particular, the invention relates to an LSD inhibitor such as a 2-cyclylcyclopropan-1-amine derivative, a phenelzine derivative and a propargylamine derivative, for use in treating or preventing thrombosis, thrombus formation, a thrombotic event or complication, or a cardiovascular disease or event.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8993808-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9149447-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9487512-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9493442-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9493450-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9186337-B2
priorityDate 2011-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID17191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420817
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41151
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID337105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID239041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409687105
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64174
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID833487
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507072

Total number of triples: 44.